Delivery Order SPE2DB24D1205-SPE2DB25FDAGZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a single-source procurement with no set-aside designation, issued under a competitive contracting mechanism. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,340.37 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded order issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,344.41 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a branded pharmaceutical product used in diabetes management,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors. This firm fixed-price delivery order, issued on September 3, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,728.19 on September 2, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen (0.5 mL) to be delivered to Conshohocken, Pennsylvania. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The contract is classified as a child award, indicating it is issued...
- The Defense Logistics Agency awarded a delivery order valued at $35,224.21 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, firm fixed price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a firm fixed price ceiling value of $6,097.91. This non-competitive delivery order is expected to be completed by August 26, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAGZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,456.89 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens. This firm fixed-price, competitively awarded delivery order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing within the federal pharmaceutical procurement marketplace. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and federal healthcare systems globally. The company's extensive federal portfolio demonstrates its capability to fulfill diverse pharmaceutical needs, and this specific award for Mounjaro—a diabetes medication—exemplifies its role in supporting the Defense Health Agency and other government healthcare programs through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.5k | 9/9/25 |